Capital Signal

Neurizon Therapeutics Limited (ASX: NUZ)

Sector: Health Care

Market cap: A$68M (as of 2 Nov 2026)

To develop its own drug discovery intellectual property for the treatment of different types of neurological diseases

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
2 Nov 2026Placement$4.3M$0.0720.9% discountFiling ↗
16 Apr 2026Placement$2.657M$0.08—Filing ↗
27 Jan 2026Rights issue$5.881M$0.08—Filing ↗
18 Sept 2025Placement$5M$0.1214.3% discountFiling ↗
23 July 2024SPP$7.8M$0.19—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
6 Jan 2026Mr Chek Loon TanEntry?% → 6.340%Filing ↗
26 Aug 2025HYBRID HOLDINGS PTY LTDEntry?% → 7.49%Filing ↗
30 Aug 2024HYBRID HOLDINGS PTY LTDEntry?% → 7.49%Filing ↗
22 July 2019HYBRID HOLDINGS PTY LTDEntry—Filing ↗

Director trades — on-market

DateDirectorTradeSource
14 Sept 2026Sergio DuchiniBought 372,960Filing ↗
30 June 2026Mr Marcus HughesBought 576,940 fully paid ordinary shares ((1) 500,000 (2) 26,778 (3) 3,340 (4) 46,822)Filing ↗
10 May 2023Mr Sam Michael WrightBought 50,000Filing ↗
10 Mar 2023Mr Sam Michael WrightBought 85,000Filing ↗
10 Mar 2023Mr Sam Michael WrightBought 185,000Filing ↗

Cash and runway

MetricValueAs ofSource
CashA$11M30 Sept 2026Filing ↗
Runway4.5 quarters30 Sept 2026Filing ↗

Ask about NUZ in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has NUZ raised money in the last year, and at what discount?
  • What was NUZ's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading NUZ…

Neurizon Therapeutics Limited (ASX: NUZ): capital raises, holders, director trades | Capital Signal